STOK Edward M. Kaye M.D. sold Stoke Therapeutics, Inc. shares — SEC Form 4SELLStoke Therapeutics, Inc.

Edward M. Kaye M.D., CEO at Stoke Therapeutics, Inc. (STOK), sold 12,848 shares at $50.00 ($642K) on 2020-11-25, disclosed to the SEC on 2020-11-25.

SEC EDGAR Filing

0001209191-20-060558

View on SEC EDGAR

Trade context

Open-market sale of $642k STOK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.

Notable60/100

Something here stands out, but not much.

Opportunistic Sell

Trade Context

•Decreased holdings by 26%
•2 insiders buying while this insider is selling
•3 other insiders also sold in last 30 days
•Stock up +73% in previous 6 months

Filing Info

Filed2020-11-25

Traded2020-11-25

Accession0001209191-20-060558

SourceSEC EDGAR (Historical)

Insider

NameEdward M. Kaye M.D.

TitleCEO

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
STOK	SELL	2026-08-18	$403K	—	Filing →
CYTK	SELL	2026-06-01	$223K	—

Get an email when an insider at STOK files

Free account. Follow STOK and up to 10 more companies.

Follow STOK for free

STOK Edward M. Kaye M.D. sold Stoke Therapeutics, Inc. shares — SEC Form 4SELLStoke Therapeutics, Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes